Celleron Therapeutics Limited
05162047
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 24/06/2025
Due 08/07/2026
Industry
Officers
director · Since 24/06/2004
PROFESSOR
BRITISH · UNITED KINGDOM · Age 68
Also on 6 other boards
Persons with Significant Control
Ingenox Therapeutics Limited
Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GA
Reg: 14127227 · Companies House · Limited By Shares
Notified 22/12/2022
Former PSCs
Prof Nicholas Barrie La Thangue
Ceased 22/12/2022
Charges0 outstanding
QUINTILES LIMITED
CompanyRankvs 275+ SIC 72110 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£2k
Balance sheet strength
Cash
£225k
Cash in the bank
Net Current Assets
£464k
Working capital
Current Assets
£490k
Current Liabilities
£26k
Fixed Assets
£100
Debtors
£264k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 18.97 | +£2 |
| 2020 | 4.66 | +£0 |
| 2019 | 7.16 | +£0 |
| 2018 | 5.54 | — |
Derived from filed accounts. Not audited figures.